Determination of Risk Factors in Children Diagnosed With Henoch-Schönlein Purpura

Objectives: This study aims to evaluate the frequency of skin, gastrointestinal, joint, and renal involvement in children with Henoch-Schönlein purpura (HSP) and investigate the risk factors for organ/system involvement. Patients and methods: The data of 186 patients (97 boys, 89 girls; mean age 7.4±2.8 years; range 1.5 to 16.5 years) who were followed-up with the diagnosis of HSP in our clinic between October 2011 and December 2013 were evaluated retrospectively. Results: Logistic regression analysis revealed that the risk of gastrointestinal system (GIS) involvement was significantly higher in patients with skin lesions in the upper extremities (p=0.002, odds ratio [OR]=3.2). The risk of joint involvement was significantly higher in girls (p=0.024, OR=2.18), in patients with soft tissue swelling (p=0.005, OR=2.63), and with low mean platelet volume (MPV) levels (p=0.008, OR=4.07). The risk of renal involvement was significantly higher in girls (p=0.047, OR=2.7), in patients >10 years (p=0.001, OR=1.4), and in patients with elevated C-reactive protein (CRP) levels (p=0.007, OR=6.57). Conclusion: Having skin lesions in the upper extremities is a risk factor for GIS involvement. Female sex, soft tissue swelling, and low MPV levels are risk factors for joint involvement. Female sex, >10 years of age, and high CRP levels are risk factors for renal involvement. Renal involvement in HSP is independent of GIS or joint involvement and very close follow-up is required in the acute period particularly in girls >10 years with high CRP levels.

Kaynakça

1. Batu ED, Ozen S. Pediatric vasculitis. Curr Rheumatol Rep 2012;14:121-9.

2. Dereli N, Ozayar E, Degerli S, Sahin S, Bulus H. A rare complication of Henoch-Schönlein Syndrome: gastrointestinal infarction and perforation. Acta Gastroenterol Belg 2012;75:274-5.

3. Ozen S, Bakkaloglu A, Dusunsel R, Soylemezoglu O, Ozaltin F, Poyrazoglu H, et al. Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol 2007;26:196-200.

4. Cakar N, Ozçakar ZB, Soy D, Uçar Y, Fitöz S, Kara N, et al. Renal involvement in childhood vasculitis. Nephron Clin Pract 2008;108:202-6.

5. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006;65:936-41.

6. Makay B, Türkyilmaz Z, Duman M, Unsal E. Mean platelet volume in Henoch-Schönlein purpura: relationship to gastrointestinal bleeding. Clin Rheumatol 2009;28:1225-8.

7. Wang X, Zhu Y, Gao L, Wei S, Zhen Y, Ma Q. Henoch-Schönlein purpura with joint involvement: Analysis of 71 cases. Pediatr Rheumatol Online J 2016;14:20.

8. Elmas AT, Tabel Y. Platelet Counts in Children With Henoch-Schonlein Purpura--Relationship to Renal Involvement. J Clin Lab Anal 2016;30:71-4.

9. Tabel Y, Inanc FC, Dogan DG, Elmas AT. Clinical features of children with Henoch-Schonlein purpura: risk factors associated with renal involvement. Iran J Kidney Dis 2012;6:269-74.

10. Chan H, Tang YL, Lv XH, Zhang GF, Wang M, Yang HP, et al. Risk Factors Associated with Renal Involvement in Childhood Henoch- Schönlein Purpura: A Meta-Analysis. PLoS One 2016;11:0167346.

11. Schmitt R, Carlsson F, Mörgelin M, Tati R, Lindahl G, Karpman D. Tissue deposits of IgA-binding streptococcal M proteins in IgA nephropathy and Henoch-Schonlein purpura. Am J Pathol 2010;176:608-18.

12. Li W, Li H, Song W, Hu Y, Liu Y, DA R, et al. Differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with complements C3 and C4 and C-reactive protein. Exp Ther Med 2013;6:1271- 1276.

13. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, et al. Prognosis of Henoch-Schönlein nephritis in children. Br Med J 1977;2:11-4.

14. Ozen S. The spectrum of vasculitis in children. Best Pract Res Clin Rheumatol 2002;16:411-25.

15. Peru H, Soylemezoglu O, Bakkaloglu SA, Elmas S, Bozkaya D, Elmaci AM, et al. Henoch Schonlein purpura in childhood: clinical analysis of 254 cases over a 3-year period. Clin Rheumatol 2008;27:1087-92.

16. Uppal SS, Hussain MA, Al-Raqum HA, Nampoory MR, Al-Saeid K, Al-Assousi A, et al. Henoch-Schönlein's purpura in adults versus children/adolescents: A comparative study. Clin Exp Rheumatol 2006;24(2 Suppl 41):S26-30.

17. Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura. Eur J Pediatr 2002;161:196-201.

18. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005;35:143-53.

19. Lardhi AA. Henoch-Schonlein purpura in children from the eastern province of Saudi Arabia. Saudi Med J 2012;33:973-8.

20. Dolezalová P, Telekesová P, Nemcová D, Hoza J. Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol 2004;31:2295-9.

21. Ha TS, Lee JS. Scrotal involvement in childhood Henoch-Schönlein purpura. Acta Paediatr 2007;96:552-5.

22. Hara Y, Tajiri T, Matsuura K, Hasegawa A. Acute scrotum caused by Henoch-Schönlein purpura. Int J Urol 2004;11:578-80.

23. Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F. Clinical outcome in children with Henoch-Schönlein nephritis. Pediatr Nephrol 2007;22:64-70.

24. Jackson SR, Carter JM. Platelet volume: laboratory measurement and clinical application. Blood Rev 1993;7:104-13.

25. Threatte GA. Usefulness of the mean platelet volume. Clin Lab Med 1993;13:937-50.

26. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011;17:47-58.

27. Yüksel O, Helvaci K, Baar O, Köklü S, Caner S, Helvaci N, et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets 2009;20:277-81.

28. Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008;75:291-4.

29. Safak S, Uslu AU, Serdal K, Turker T, Soner S, Lutfi A. Association between mean platelet volume levels and inflammation in SLE patients presented with arthritis. Afr Health Sci 2014;14:919-24.

30. Lee YH, Kim YB, Koo JW, Chung JY. Henoch-Schonlein Purpura in Children Hospitalized at a Tertiary Hospital during 2004-2015 in Korea: Epidemiology and Clinical Management. Pediatr Gastroenterol Hepatol Nutr 2016;19:175-185.

31. Kidney Disease Improving Global Outcomes (KDIGO) guidelines on glomerulonephritis. Henoch- Schönlein purpura nephritis. Kidney Int Suppl 2012;2:218-20.

32. Davin JC, Coppo R. Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schönlein purpura nephritis. Pediatr Nephrol 2013;28:1897-903.

33. Ronkainen J, Ala-Houhala M, Huttunen NP, Jahnukainen T, Koskimies O, Ormälä T, et al. Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria. Clin Nephrol 2003;60:80-4.

34. Davin JC, Coppo R. Henoch-Schönlein purpura nephritis in children. Nat Rev Nephrol 2014;10:563- 73.

35. Mao Y, Yin L, Huang H, Zhou Z, Chen T, Zhou W. Henoch-Schönlein purpura in 535 Chinese children: clinical features and risk factors for renal involvement. J Int Med Res 2014;42:1043-9.

36. Ozturk K, Ekinci Z. Is neutrophil-to-lymphocyte ratio valid to predict organ involvement in Henoch- Schönlein purpura? Rheumatol Int 2016;36:1147-8.

37. Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Hölttä T, et al. Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children. Arch Dis Child 2010;95:877-82.

Kaynak Göster

  • ISSN: 2148-5046
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2014

3.5b 2.6b

Sayıdaki Diğer Makaleler

Short-Term Effect of Topical Cetylated Fatty Acid on Early and Advanced Knee Osteoarthritis: A Multi-Center Study

Alarico ARIANI, Simone PARISI, Giacomo M GUIDELLI, Marco BARDELLİ, Augusto BERTINI, Enrico FUSARO

The Role of Familial Mediterranean Fever Gene Mutation in Treatment of Infantile Colitis With Resistant Perianal Fistula

MAŞALLAH BARAN, YELİZ ÇAĞAN APPAK, Pınar GARİPÇİN, Yavuz DEMİRÇELİK, Emel Ebru PALA, Berk OZYILMAZ, MİRAY KARAKOYUN, Orkan ERGÜN

Peripheral Neuropathy Presenting as Myopathy That was Confused With Inflammatory Myositis

Younghoon KIM, Yunsuek KIM, So Young JİN, Hak Jae ROH, Hyun sook KIM

Reliability and Validity of Turkish Version of Short Form of the Social Role Participation Questionnaire in Patients With Ankylosing Spondylitis

YEŞİM AKYOL, YASEMİN ULUS, YÜKSEL TERZİ, Ayhan BİLGİCİ, ÖMER KURU

Cathepsin G and Its Role in Inflammation and Autoimmune Diseases

Siming GAO, Honglin ZHU, Xiaoxia ZUO, Hui LUO

Tumor-Associated Antigens in Rheumatoid Arthritis Interstitial Lung Disease or Malignancy?

GÖKHAN SARGIN, Reyhan KOSE, TAŞKIN ŞENTÜRK

Effectiveness of Ultrasound Therapy on Myofascial Pain Syndrome of the Upper Trapezius: Randomized, Single-Blind, Placebo-Controlled Study

Mustafa Aziz YILDIRIM, KADRİYE ÖNEŞ, Gökşen GÖKŞENOĞLU

Bone Morphogenetic Protein 6 Polymorphisms are Associated With Systemic Lupus Erythematosus Susceptibility in the Korean Population

Ji su MO, Soo cheon CHAE

A Cross Sectional Study of the Impact of Human Immunodeficiency Virus, Hepatitis B Virus and Hepatitis C Virus on Rheumatoid Factor Production

Etienne Atabonkeng PHILEMON, Christopher TUME, Marie Claire OKOMO ASSOUMOU, Salomon TCHUANDOM BONSI, Ikomey Mondide GEORGES, Herve OUAMBO FOTSO, Lyonga EMILYA, Mesembe Tonga MARTHA, Madelaine NGANDEU-SINGWE

Clinical and Serologic Characteristics of Systemic Lupus Erythematosus in the Arab World: A Pooled Analysis of 3,273 Patients

Marwan ADWAN